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(57) ABSTRACT 
Kay den, 
Systems and methods for providing an optimal treatment 
plan for delivering a prescribed radiation dose to a pre-
defined target volume within a patient using an external 
beam radiation delivery unit are provided. One such method 
comprises: receiving information corresponding to at least 
one parameter related to intensity-modulated radiation 
therapy (IMRT) to be used in developing the optimal treat-
ment plan; receiving information corresponding to at least 
one clinical objective related to a target volume and a critical 
structure; developing a treatment plan optimization model 
based on a plurality of variables corresponding to the at least 
one parameter related to IMRT and the at least one clinical 
objective which define a global system; and developing a 
globally optimal treatment plan which optimizes the at least 
one clinical objective subject to the at least one parameter. 
26 Claims, 18 Drawing Sheets 
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SYSTEMS AND METHODS FOR GLOBAL 
OPTIMIZATION OF TREATMENT 
PLANNING FOR EXTERNAL BEAM 
RADIATION THERAPY 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
Thus, the basic strategy of external beam radiation 
therapy is to utilize multiple beams of radiation from mul-
tiple directions to "cross-fire" at the target volume. In that 
way, radiation exposure to normal tissue is kept at relatively 
low levels, while the dose to the tumor cells is escalated. 
Thus, the main objective of the treatment planning process 
involves designing a beam profile, for example, a collection 
of beams, that delivers a necrotic dose of radiation to the 
tumor volume, while the aggregate dose to nearby critical 
10 structures and surrounding normal tissue is kept below 
established tolerance levels. 
This application is a continuation-in-part application of 
U.S. Utility Application entitled "Systems and Methods for 
Global Optimization of Treatment Planning for External 
Beam Radiation Therapy," having Ser. No. 10/341,257, filed 
Jan. 13, 2003, now U.S. Pat. No. 6,741,674, which is a 
continuation application of U.S. Utility Application entitled 
"Systems and Methods for Global Optimization of Treat- 15 
ment Planning for External Beam Radiation Therapy," hav-
ing Ser. No. 09/706,915, filed Nov. 6, 2000 (now U.S. Pat. 
No. 6,546,073 Bl), which claims priority to U.S. Provisional 
Application entitled "Systems and Methods for Global Opti-
mization of Treatment Planning for External Beam Radia- 20 
tion Therapy," having Serial No. 60/164,029, filed Nov. 5, 
1999, each of which are entirely incorporated herein by 
reference. This application also claims priority to U.S. 
Provisional Application No. 60/433,657, filed Dec. 18, 
2002, which is entirely incorporated herein by reference. 
One existing method for treatment planning in external 
beam radiation therapy is standard manual planning. This 
method is referred to as forward planning because the 
physician solves the direct problem of determining the 
appropriate dose distribution given a known set of beam 
characteristics and beam delivery parameters. In other 
words, standard manual planning involves a trial-and-error 
approach performed by an experienced physician. The phy-
sician attempts to create a plan that is neither complex nor 
difficult to implement in the treatment delivery process, 
while approximating the desired dose distribution to the 
greatest extent possible. For instance, the physician may 
choose how many isocenters to use, as well as the location 
25 in three dimensions, the collimator size, and the weighting 
to be used for each isocenter. A treatment planning computer 
may calculate the dose distribution resulting from this 
preliminary plan. Prospective plans are evaluated by view-
ing isodose contours superimposed on anatomical images 
TECHNICAL FIELD 
The present invention relates generally to treatment plan-
ning for external beam radiation therapy, and more particu-
larly, to systems and methods for global optimization of 
treatment planning for external beam radiation therapy. 
BACKGROUND 
External beam radiation therapy is a well-known treat-
ment option available to the radiation oncology and neuro-
surgery communities for treating and controlling certain 
central nervous systems lesions, such as arteriovenous mal-
formations, metastatic lesions, acoustic neuromas, pituitary 
tumors, malignant gliomas, intracranial tumors, and tumors 
in various parts of the body (e.g., lung, breast, prostate, 
pancreas, etc.). As the name implies, the procedure involves 
the use of external beams of radiation directed into the 
patient at the lesion using either a gamma unit (referred to 
30 and/or with the use of quantitative tools such as cumulative 
dose-volume histograms (DVH's). 
Standard manual planning has many disadvantages. This 
iterative technique of plan creation and evaluation is very 
cumbersome, time-consuming, and far from optimal. Thus, 
35 manual planning results in much higher costs for patients 
and insurers. The physician or other experienced planner can 
evaluate only a handful of plans before settling on one. Thus, 
standard planning has very limited success in improving 
local tumor control or reducing complications to normal 
40 tissue and critical structures, and as a result, greatly limits 
the quality-of-life for patients. In standard manual planning, 
there is no mechanism for allowing the advance imposition 
of clinical properties, such as, for example, an upper bound 
on dose received by normal tissue or the specific shape of 
45 dose-response curves to the tumor and to critical structures, 
on the resulting plans. Furthermore, manual planning is 
subjective, inconsistent, far from optimal, and only enables 
a small amount of treatment plans to be examined by the 
as a Gamma Knife), a linear accelerator, or similar beam 
delivery apparatus. Although treating the lesions with the 
radiation provides the potential for curing the related disor-
der, the proximity of critical normal structures and surround-
ing normal tissue to the lesions makes external beam radia- 50 
ti on therapy an inherently high risk procedure that can cause 
severe complications. Hence, the primary objective of exter-
nal beam radiation therapy is the precise delivery of the 
desired radiation dose to the target area defining the lesion, 
while minimizing the radiation dose to surrounding normal 
tissue and critical structures. 
physician. 
Another method for treatment planning in external beam 
radiation therapy employs computer systems to optimize the 
dose distributions specified by physicians based on a set of 
preselected variables. This approach is known as inverse 
planning in the medical community because the computer 
55 system is used to calculate beam delivery parameters that 
best approximate the predetermined dose, given a set of 
required doses, anatomical data on the patient's body and the 
target volume, and a set of preselected or fixed beam 
orientation parameters and beam characteristics. In order to 
The process of treating a patient using external beam 
radiation therapy consists of three main stages. First, a 
precise three-dimensional map of the anatomical structures 
in the location of interest (target volume) is constructed 
using any conventional three-dimensional imaging technol-
ogy, such as computed tomography (CT) or magnetic reso-
nance imaging (MRI). Second, a treatment plan is developed 
for delivering a predefined dose distribution to the target 
volume that is acceptable to the clinician. Finally, the 
treatment plan is executed using an accepted beam delivery 
apparatus. 
60 solve the complex problem of arriving at an optimal treat-
ment plan for the domain of possible variables, all existing 
methods of inverse treatment planning fix at least a subset of 
the set of variables. For example, a particular modality of 
external beam radiation therapy may include the following 
65 domain of possible variables: (1) number of beams, (2) 
configuration of beams, (3) beam intensity, (4) initial gantry 
angle, (5) end gantry angle, (6) initial couch angle, (7) end 
US 7,046,762 B2 
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couch angles, (8) prescription dose, (9) target volume, and 
(10) set of target points. State of the art inverse treatment 
planning approaches preselect a subset of these variables 
and fix them during the optimization calculation. 
Despite its obvious advantages over the standard manual 
approach, existing inverse treatment planning approaches 
have several disadvantages and inadequacies. As described 
above, these approaches do not incorporate each of the 
domain of possible variables into the optimization calcula-
tion. Instead, these approaches fix at least a subset of these 10 
variables to arrive at an "optimal" treatment plan. This type 
of "local optimization" is inherently problematic because it 
does not allow the full flexibility of choosing different beam 
geometries, beam orientation parameters, and beam param-
eters, imposing dose limits, and placing constraints on 15 
physical planning parameters. In other words, these 
approaches do not enable "global optimization" of treatment 
planning for external beam radiation therapy. Therefore, 
these approaches are limited by "less than optimal" treat-
ment plans and, consequently, are unable to adequately 20 
control tumor growth or reduce normal tissue complications. 
Furthermore, there are an infinite number of possible treat-
ment plans in inverse treatment plarming, and existing 
methods only look at a small subset of potential plans and 
select the "best" from the subset. Thus, the resulting treat- 25 
ment plan is not a globally optimal plan. 
4 
critical structures are near the tumor, improves the percent-
age of tumor volume covered by a prescription isodose line, 
reduces the ratio of the maximum dose to the prescribed 
dose, improves the ratio of the volume of the prescribed 
isodose surface to the target volume, and improves the ratio 
of the maximum dose received by normal tissue to the 
prescribed dose. 
Briefly described, the systems according to the present 
invention for providing an optimal treatment plan have three 
main components. The systems have a user interface for 
enabling a user to specify at least one parameter related to 
IMRT, at least one constraint, and at least one clinical 
objective; a treatment plan modeling module configured to 
develop a treatment plan optimization model containing a 
plurality of variables corresponding to the at least one 
parameter related to IMRT, the at least one constraint, and 
the at least one clinical objective; and a global optimization 
module configured to calculated a globally optimal treat-
ment plan which optimizes the at least one clinical objective 
subject to the at least one parameter related to IMRT and the 
at least one constraint. The systems may also include a visual 
evaluation functionality which is adapted to display infor-
mation related to the optimal treatment plan to a physician. 
The present invention can also be viewed as providing 
methods for providing an optimal treatment plan for deliv-
ering a prescribed radiation dose to a predefined target 
volume within a patient using an external beam radiation 
Furthermore, existing inverse treatment planning are not 
well-suited for use with newer external beam radiation 
therapy modalities. Recent technological advances have 
resulted in sophisticated new devices and procedures for 
external beam radiation delivery, such as, for example, 
high-resolution multi-leaf collimators, intensity-modulated 
modulated radiation therapy (IMRT), and non-coplanar arc 
stereotactic radiosurgery (NASR). Unlike conventional 
radiation therapy where radiation profiles are altered via the 
use of a limited number of wedges, beam blocks and 
compensating filters, these new devices and procedures 
allow a large collection of beams to be shaped in any desired 
fashion with regard to both the geometrical shape and 
fluence across the field to create fixed or moving nonuniform 
beams of photons or charged particles. While the flexibility 
and precise delivery capability resulting from these 
advances is clearly advantageous, their full potential cannot 
30 
delivery unit. Briefly, one such method involves receiving 
information corresponding to at least one parameter related 
to intensity-modulated radiation therapy (IMRT) to be used 
in developing the optimal treatment plan: receiving infor-
mation corresponding to at least one clinical objective 
35 
related to a target volume and a critical structure; developing 
a treatment plan optimization model based on a plurality of 
variables corresponding to the at least one parameter related 
to IMRT and the at least one clinical objective which define 
a global system: and developing a globally optimal treat-
40 ment plan which optimizes the at least one clinical objective 
subject to the at least one parameter. 
be realized using "local optimization" schemes which do not 
incorporate each of the domain of possible variables into the 45 
optimization calculation, but instead fix at least a subset of 
these variables to arrive at an "optimal" treatment plan. 
Other systems, methods, features, and advantages of the 
present invention will be or become apparent to one with 
skill in the art upon examination of the following drawings 
and detailed description. It is intended that all such addi-
tional systems, methods, features, and advantages be 
included within this description, be within the scope of the 
present invention, and be protected by the accompanying 
claims. 
Thus, an unaddressed need exists in the industry to 
address the aforementioned deficiencies and inadequacies. 
SUMMARY 
50 
BRIEF DESCRIPTION OF THE DRAWINGS 
The present invention solves the problems described 
above by providing systems and methods for providing a 
globally optimal treatment plan for delivering a prescribed 
radiation dose to a target tumor volume within a patient 
using an external beam radiation source. The present inven-
tion enables a physician performing external beam radiation 
therapy to develop a globally optimal treatment plan, which 
results in improved patient care and improved efficiency. For 
example, in the field of external beam radiation therapy, the 
present invention reduces normal tissue complications, 
improves tumor control, enables physicians to evaluate a set 
The systems and methods according to the present inven-
tion can be better understood with reference to the following 
55 drawings. 
60 
of globally optimal solutions, reduces the time and cost 
associated with producing a treatment plan, eliminates trial 65 
and error visual optimization, enables physicians to perform 
radiation therapy in complex situations, such as where 
FIG. 1 is a functional block diagram of one embodiment 
of a system according to the present invention. 
FIG. 2 is a functional block diagram of another embodi-
ment of a system according to the present invention. 
FIG. 3 is a block diagram of a preferred implementation 
of the system illustrated in FIG. 2. 
FIG. 4 is a flowchart illustrating the functionality and 
operation of the system illustrated in FIGS. 2 and 3. 
FIG. 5 is a functional block diagram of an embodiment of 
the systems of FIGS. 1-4, for intensity modulated radiation 
therapy (IMRT) treatment planning. 
US 7,046,762 B2 
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FIG. 6 is a screenshot of an embodiment of a user input 
screen supported by the user interface of FIG. 5 for enabling 
a user to designate values for a candidate beam profile for 
IMRT treatment planning. 
FIG. 7 is a screenshot of another embodiment of a user 
input screen supported by the user interface of FIG. 5 for 
enabling a user to designate various dose and clinical 
parameters for IMRT treatment planning. 
6 
a Gamma Knife, or any other external device capable of 
providing a radiation source. External beam delivery unit 12 
may comprise a plurality of external beams having variable 
intensity, a plurality of collimators for adjusting the size of 
the beams, and a mechanism for moving the unit with 
respect to a patient positioned within a stereotactic frame in 
order to adjust the angle and entry point of each radiation 
beam. 
FIG. 8 is a screenshot of another embodiment of a user 
input screen supported by the user interface of FIG. 5 for 10 
enabling a user to designate various dose and clinical 
constraints and objectives for IMRT treatment planning. 
System 10 also contemplates using various radiation 
modalities with external beam delivery unit 12. For 
example, system 10 may be used with static conformal 
radiation therapy (SCRT), non-coplanar arc stereotactic 
radiosurgery (NASR), intensity modulated radiation therapy 
(IMRT), and intensity modulated arc therapy (IMAT). 
FIG. 9 is a diagram illustrating the functional connectivity 
and data flow for an embodiment of the dose calculation 
module of FIG. 5 for IMRT treatment planning. 
FIG. 10 is a functional block diagram illustrating the 
architecture, operation, and/or functionality of an embodi-
ment of the treatment plan modeling module of FIG. 5 for 
IMRT treatment planning. 
15 
FIG. 11 is a flow chart illustrating the architecture, 20 
operation, and/or functionality of an embodiment of the 
verification algorithm module of FIG. 10 for IMRT treat-
ment planning. 
SCRT involves the use of three-dimensional computer 
planning systems to geometrically shape the radiation field 
to ensure adequate coverage of the target, while sparing 
normal tissue. The tools for SCRT include patient-specific 
CT data, beam's-eye-view (BEV) treatment planning, and 
multileaf collimators (MLC). Guided by the target contours 
identified in the CT images, beam orientations are chosen 
and beam apertures are accurately delineated using BEV. 
The beam aperture can be fabricated with conventional 
blocks or defined by MLC. The dose distribution within the 
field is determined by choice of beam intensity and simple 
modulators such as wedges and tissue compensators. 
FIG. 12 is a flow chart illustrating the architecture, 
operation and/or functionality of an embodiment of the 25 
treatment planning algorithm module of FIG. 10 for IMRT 
treatment planning. NASR is a technique used for treating brain tumors. 
FIG. 13 is a block diagram illustrating an embodiment of 
the model file of FIG. 10 for IMRT treatment planning. 
FIG. 14 is a functional block diagram illustrating the 30 
architecture, operation and/or functionality of an embodi-
ment of the global optimization module of FIG. 5 for IMRT 
treatment planning. 
Radiosurgery is distinguished from conventional external 
beam radiation therapy of the central nervous system by its 
localization and treatment strategy. In radiosurgery, the 
target volume of tissue is much smaller (tumors 10-35 mm 
in diameter), the number of fractions (treatment sessions) is 
much less, and the dose per fraction is much larger than in 
conventional radiotherapy. Radiosurgery involves the use of 
external beams of radiation guided to a desired point within 
the brain using a precisely calibrated stereotactic frame 
FIG. 15 is a functional block diagram illustrating the 
architecture, operation and/or functionality of an embodi- 35 
ment of the optimization module of FIG. 14 for IMRT 
treatment planning. mechanically fixed to the head, a beam delivery unit, such as 
a LINAC Gamma Knife, and three-dimensional medical 
imaging technology. For LINAC radiosurgery, the table on 
which the patient lies and the beam delivery unit are capable 
of rotating about distinct axes in order to adjust the angle and 
FIG. 16 is a screenshot of an embodiment of a beam 
intensity tool supported by the system of FIG. 5. 
FIG. 17 illustrates the beam intensity data of FIG. 16 in 40 
numerical and tabular form. 
FIG. 18 is a block diagram illustrating various alternative 
tools supported by the system of FIG. 5 for enabling a user 
to evaluate the IMRT treatment plan. 
DETAILED DESCRIPTION 
Having summarized the invention above, reference is now 
made in detail to the description of the invention as illus-
trated in the drawings. While the invention will be described 
in connection with these drawings, there is no intent to limit 
it to the embodiment or embodiments disclosed. On the 
contrary, the intent is to cover all alternatives, modifications 
and equivalents included within the spirit and scope of the 
invention as defined by the appended claims. 
System Overview 
FIG. 1 illustrates a functional block diagram of a preferred 
embodiment of a system 10 according to the present inven-
tion for enabling global optimization of treatment planning 
for external beam radiation therapy. System 10 is connected 
to an external beam delivery unit 12, visual evaluation 
functionality 14, and three-dimensional imaging system 16. 
External beam delivery unit 12 may be any conventional 
equipment used in external beam radiation therapy for 
delivering doses of radiation to a target volume 20 within a 
patient, such as, for example, a linear accelerator (LINAC), 
entry point of a radiation beam. The tissue affected by each 
beam is determined by the patient's position within the 
stereotactic frame, by the relative position of the frame in 
45 relation to the beam delivery unit, by collimators that adjust 
the size of the beam, and by the patient's anatomy. Addi-
tionally, the intensity of each beam can be adjusted to govern 
its dose contribution to each point. 
IMRT is a recently developed treatment modality in 
50 radiotherapy. In IMRT the beam intensity is varied across 
the treatment field. Rather than being treated with a single, 
large, uniform beam, the patient is treated instead with many 
very small beams, each of which can have a different 
intensity. When the tumor is not well separated from the 
55 surrounding organs at risk-such as what occurs when a 
tumor wraps itself around an organ-there may be no 
combination of uniform intensity beams that will safely 
separate the tumor from the healthy organ. In such instances, 
adding intensity modulation allows more intense treatment 
60 of the tumor, while limiting the radiation dose to adjacent 
healthy tissue. 
IMAT is a form of IMRT that involves gantry rotation and 
dynamic multileaf collimation. Non-coplanar or coplanar 
arc paths are chosen to treat the target volume delineated 
65 from CT images. The arcs are chosen such that intersecting 
a critical structure is avoided. The fluence profiles at every 
5 degrees are similar to a static IMRT field. As the gantry 
US 7,046,762 B2 
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rotates, the dynamic MLC modulates the intensity to deliver 
the dose to the target volume while sparing normal tissue. 
The large number of rotating beams may allow for a more 
conformal dose distribution than the approach of multiple 
intensity modulated beams. 
Thus, the systems and methods of the present invention 
are not limited to a particular type of external beam delivery 
unit 12 or a particular modality, but instead may employ any 
type of external beam delivery unit or radiation modality. 
Visual evaluation functionality 14 may be any conven- 10 
tional imaging module adapted to interface with system 10 
and capable of visually displaying an optimal treatment plan 
for delivering radiation to a patient using external beam 
delivery unit 12. Visual evaluation functionality 14 may be 
a computer monitor, a television monitor, any type of 15 
printout from a computer, or any other imaging module used 
by physicians to evaluate the effectiveness of a particular 
treatment plan for a patient. For example, visual evaluation 
functionality 14 may be configured to enable physicians to 
view dose-volume histograms and isodose surfaces for a 20 
treatment plan overlayed with a diagram of the target 
volume and surrounding areas, including normal surround-
ing tissue and critical structures. 
Three-dimensional imaging system 16 may be any three-
dimensional imaging technology used to delineate target 25 
volume 20 of a tumor or similar region within a patient, such 
8 
dose calculation points from the imaging coordinate systems 
are transformed via a coordinate system transformation 
algorithm to the stereotactic coordinate system. An auto-
mated arc selection method employing computational geom-
etry techniques is used to select a representative collection 
of candidate arcs. 
As described above, system 10 is not limited to a par-
ticular type of apparatus for external beam delivery unit 12 
or a particular modality. Nonetheless, for exemplary pur-
poses, system 10 will be described with respect to a pre-
ferred method using LINAC arcing radiosurgery. 
In LINAC arcing radiosurgery, the following treatment 
parameters define an arc: a target point location variable t; 
collimator size C, gantry initial and end angles 8, and 8e and 
couch angle cp. The isocenters for candidate arcs are chosen 
in 2 mm intervals and reside in the target volume. The 
candidate arcs vary the couch and gantry angles in 1 ° 
increments from -90° to 90° and 0° to 359°, respectively. 
These candidate beam orientation parameters (couch and 
gantry angles) are selected so that they match the beam 
orientations selected by clinicians manually. Twelve circular 
collimator sizes are applied to the candidate arcs, ranging 
from 12.5 to 40 mm in 2.5 mm steps. The resulting collec-
tion of beams comprise a large set of candidate beams used 
for instantiating a treatment plan optimization model used 
by treatment plan modeling processor 24. as, for example, a computed tomography (CT) system, a 
magnetic resonance imaging (MRI) system, or any similar 
system. It should be understood by skilled persons in the art 
that there are many ways to capture images oflesions within 
a human body, and, therefore, this invention should not be 
limited to any particular type of imaging system. The 
important aspect is that imaging system 16 is capable of 
identifying the contours of target volume 20 along with 
surrounding normal tissues and critical structures. 
Treatment Plan Oiptimization Model/Treatment Plan Mod-
30 eling Module 
As shown in FIG. 1 and mentioned above, system 10 
comprises treatment plan modeling module 24 and global 
optimization module 22. Treatment plan modeling module 
24 receives inputs 18, and based on these inputs, creates a 
35 treatment plan optimization model. The treatment plan opti-
mization model incorporates every potential variable 
included within input 18. In other words, the treatment plan 
optimization model represents a global optimization of 
every potential variable within the system. As will be 
As shown in FIG. 1, system 10 comprises two main 
components: global optimization module 22 and treatment 
plan modeling module 24. FIG. 2 shows an alternative 
embodiment of a system 11 according to the present inven-
tion. System 11 is similar to system 10 except that it 40 
incorporates a third component, dose calculation module 26. 
Each of these components will be described in detail below. 
described in detail below, upon completion, treatment plan 
modeling module 24 provides the resulting treatment plan 
optimization model to global optimization module 22 where 
an optimal treatment plan is determined based on inputs 18. 
System Input A preferred embodiment of a treatment plan optimization 
45 model will now be described. Given a collection of selected Referring again to FIG. 1, system 10 receives various 
inputs from imaging system 16, as well as input data 18. 
Although in the preferred embodiment input data 18 repre-
sents all information input into system 10 not received from 
imaging system 16, it should be noted that input data 18 may 
actually come from any source. For example, input data 18 50 
may be received by system 10 as a manual input by a 
physician or automatic input via a computer directed by a 
physician. FIG. 1 is merely illustrating by way of example 
that system 10 receives information related to target volume 
20 via imaging system 16 and that all other input is referred 55 
to as input data 18. 
Input data 18 to system 10 includes CT and/or MRI 
images of target volume 20. The contours of target volume 
20 and surrounding normal tissue and critical structures are 
identified and segmented using the medical images. These 60 
anatomical contours are used as inputs to system 10. Other 
inputs include clinical planning information such as pre-
scription dose; target lower and upper bounds on the radia-
tion dose delivered to the tumor volume, nearby healthy 
tissue, and critical structures; choice of possible isocenters; 65 
and desired number of beams, isocenters, and couch angles 
used in the final physical plan. The anatomical contours and 
arcs indexed as {1, ... , NA}, comprised of target points 
{1, ... , N,} and couch angles {1, ... , Nq,} (note that each 
arc associates with a specified collimator size, gantry initial 
and end angles, target position, and couch angle), the 
preferred treatment plan optimization model incorporates 
non-negative continuous variables to record the intensity 
used for each arc. If an arc is used, thus indicating that the 
intensity is greater than zero, then it contributes a certain 
amount of radiation dosage to each voxel in target volume 
20. Thus, once the set of potential arc intensities is specified, 
the total radiation dose received at each voxel can be 
modeled. For example, in the preferred treatment plan 
optimization model, wa~O denotes the intensity (weight) of 
arc a. Then the total radiation dose at a voxel P is given by 
the following expression: 
Equation 1 
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where Dp a denotes the dose contribution to voxel P from arc 
a as give~ by the following expression: 
DP,a~S(C)f s;8"TMR(8,<j>mdP,a,rP,mCP) OAR(8,<j>"' 
aP,mrP,mCp)IVSQ(8,<j>"'ap,a,rP,a)d8 Equation 2 
10 
where Tis the maximum number of target points acceptable 
by the physician for the particular patient. Although com-
plications from radiosurgery treatments may increase with 
the number of isocenters, it has been shown that for highly 
irregular shaped tumor volumes, multiple isocenters may 
improve the conformity of the high dose region. With 
current state of the art methods, determining an "optimal" 
beam configuration with multiple target points is extremely 
difficult and time consuming. The systems and methods of 
DP a may be calculated using standard dose calculation 
tools 'and merely included with input data 18. As shown in 
FIG. 2, an alternative embodiment of a system 11 may 
employ an internal dose calculation module 26 to perform 
this calculation. Dose calculation module 26 may employ 
computational geometry and measured dosimetry param-
eters in a semi-empirical formulation to calculate Dp a· For 
instance, to calculate the dose from a fixed beam, s~y at a 
point Pin the brain, a ray is formed joining Panda point on 
the central axis of the radiation beam. Dose calculation 15 
10 the present invention enable clinicians to include such 
constraints within the model to assist in determining an 
optimal treatment plan. 
module 26 may employ a computation method which uses 
measured dosimetry parameters obtained from a water phan-
tom. The parameters may include: tissue maximum ratios 
(TMR), total scatter correction factors (S), inverse square 
correction (IVSQ), and off-axis ratio (OAR). The depth, d, 
of tissue penetrated by the central ray of the radiation beam, 
and the depth, a:, of tissue penetrated by the ray formed by 
connecting the dose calculation voxel P to the radiation 
source are computed by a ray tracing method. The distance, 
The preferred embodiment of the treatment plan optimi-
zation model may also constrain the number of couch 
angles, and the number of arcs used in the resulting plan due 
to the physical requirement of adjusting the equipment to 
achieve the desired configurations for each round of irra-
diation. For example, the treatment plan optimization model, 
may employ 0/1 integer variable cp1, to model the use of 20 couch angle j, and 0/1 integer variable ~a to model the use 
of arc a. In this manner, when w a (w J is positive, then cp1 
(~a) will be set to 1. These cbnstraints may take the 
following form: 
r, from the dose calculation voxel to the central ray is also 25 
computed. Using the values d, a:, and r, the measured 
dosimetry parameters are calculated for the point P. The dose 
per monitor unit deposited by one arc of the gantry is the 
sum of a set of static beams which approximate this arc. The 
total dose deposited to a point (DP a) is the summation of the 30 
dose over all arcs. ' 
The preferred embodiment of the treatment plan optimi-
zation model may also incorporate a variety of desirable 
constraints. For example, clinically prescribed lower and 
upper bounds, say LP and U F' for the radiation dose at voxel 35 
P can be incorporated with Equation 1 to form the following 
dosimetric constraints: 
NA NA Equation 3 40 
2= Dp,aWa :2::: Lp and 2= Dp,aWa::; Up 
a=l a=l 
N¢ 
Wai :;; Na/Pi and 2= <Pi:;; <I> 
j=l 
Na 




where Na and Ra are constants and can be chosen as the 
largest pci'ssible intensity emitted from arc a, respectively, 
and <I> and B are the maximum number of couch angles 
allowed and beam configurations desired in the optimal 
plan, respectively. 
In a similar manner, the treatment plan optimization 
model may also constrain the collimator size and the number 
of distinct gantry angles used in the resulting plans. In 
addition, it may also impose a minimum beam intensity for 
each arc to ensure that the resulting plan is practical. These 
Note that a is characterized by the target point, couch angles, 
collimator size, and gantry initial and end angles. Thus, a 
could be more accurately referred to as a,,c,e;,e",<1>· However, 
for brevity of notation, subscripts are listed only as needed 
to enhance clarity. 
45 constraints may be important if, in absence of such restric-
tions, the optimization system returns plans involving, say, 
hundreds of distinct configurations. Too many configura-
tions may be physically difficult to manage, and it will be 
impractical to deliver a very complex plan. The treatment 
50 plan optimization model is configured to enable dose cal-
culation module 26 to return a realistic plan which can be 
carried out in a reasonably easy fashion in the treatment 
delivery room. 
The preferred embodiment of the treatment plan optimi-
zation model may also constrain the characteristics of beam 
arrangements from external beam delivery unit 12. To 
control the number of target points specified by the optimal 
plan, the treatment plan optimization model defines a 0/1 
indicator variable ~ to denote if target point j is used or not. 55 
The following constraints capture the use of target point j in 
the resulting plan when an arc with target point j is used. 
The treatment plan optimization model may also incor-
porate additional constraints to enforce clinical properties 
desired for individual patients. A variety of optimization 
objectives can be incorporated with these constraints to 
direct the selection of a treatment plan. For example, one 
possible approach is to find a maximal feasible subsystem 
N, Equation 4 60 among the dosimetric constraints. Clinically, this translates 
into finding a beam configuration which gives the maximum Waj ::; Ma/J and 2= lj::; T 
j=l 
Here, Ma is a positive constant and can be selected as the 
largest pci'ssible beam intensity among candidate arcs having 
target point j. The second constraint can then be imposed, 
percentage of tumor volume, critical structure and normal 
tissue satisfying their respective target dose levels. Due to 
the proximity of critical structures and the tumor volume, it 
65 is not possible to find a beam geometry and intensity which 
satisfies all the dosimetric constraints given in Equation 3. In 
this case, the treatment plan optimization model may include 
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an indicator variable incorporated into each constraint to 
capture whether or not the desired dose bound is achieved. 
Alternatively, the treatment plan optimization model may 
be configured to seek a treatment plan which results in the 
minimum deviation from the clinical prescription bounds. In 
this case, continuous variables can be added to the con-
straints in Equation 3 to measure the deviations from the 
lower and upper bound for each voxel P. 
In the preferred embodiment of the systems and methods 
12 
Minimizing the sum of the variables fp has the effect of 
providing a uniform dose distribution on the tumor volume 
while producing a steep dose gradient outside of the tumor 
volume. Thus, even in the absence of a critical structure 
constraining the treatment plan, the dose calculation model 
ensures that proximal normal tissues receive minimal dose 
due to rapid dose fall-off. 
Global Optimization Module 
of the present invention, the treatment plan optimization 10 
model employs a mixed integer progranmiing approach to 
determine an optimal treatment plan which guarantees 100% 
coverage to tumor volume while minimizing the dose 
received by proximal critical structures and/or normal tissue. 
Global optimization module 22 receives the treatment 
plan optimization model from treatment plan modeling 
module 24 and input 18. Based on this information, global 
optimization module 22 solves instances of the treatment 
plan optimization model. In the preferred embodiment, a 
classical branch-and-bound approach is used to determine a 
true global optimal solution. Moreover, the "intelligent" 
search mechanism of the branch-and-bound method enables 
large sections of the solution space to be eliminated from 
consideration-knowing that no solution within can be 
In particular, instead of providing upper and lower dose 15 
bounds, the clinician inputs the desired prescription dose 
received by the tumor volume. In this embodiment, the 
treatment plan optimization model formulates the problem 
as: 
Minimize 
Subject to the constraints: 
NA 





ajE{l, ... ,NA},jE{l, ... ,N,) 
a E {l, ... , NA) 
In Equation 7, PRDOSE is the clinical prescription dose for 
the predefined tumor volume PTV, T is the maximum 
number of target points desired by the physicians for the 
particular patient, and <I> and B are the maximum number of 
couch angles allowed and beam configurations desired in the 
optimal plan, respectively. As described above, Ma, Na, and 
Ra are positive constants and can be chosen as the lb-gest 
intensity possible emitted from a single arc. In Equation 7, 
the variable fp denotes the amount of irradiation exceeding 
the prescription dose at point P. Since fp is nonnegative, the 
dose calculation model ensures that point P will receive at 
least the prescription dose. For points P on the tumor 
surface, which separates the tumor volume from the normal 
tissue, in addition to measuring the excess radiation to the 
tumor surface, f P can also be viewed as a measure of 
radiation to the immediately surrounding normal tissue. 
20 
optimal-without actually examining each solution within. 
The branch-and-bound is a tree search approach where, at 
each node of the tree, certain binary variables are fixed to 
zero or one, and the remaining binary variables are relaxed 
(i.e., allowed to assume any value between zero and one). 
25 This results in a linear program (LP) being associated with 
each node of the tree. The LP at the root node is simply the 
original 0/1 mixed integer progranmiing (MIP) instance with 
all of the binary variables relaxed. The tree is constructed 
Equation 7 
50 
such that the binary variables fixed in a parent node will be 
fixed identically in any of its children, and each child will 
have an additional binary variable fixed to zero or one. 
Typically, children are formed in pairs as follows. Assume 
55 that the LP at a given node is solved, and one or more of the 
relaxed binary variables is fractional in the optimal solution. 
One selects such a fractional binary variable and branches 
on it. In other words, two child nodes are formed; one with 
60 the selected binary variable fixed to zero, and the other with 
the selected binary variable fixed to one. Of course, each 
child also inherits all of the fixed binary variables of its 
parent. Note that the objective value of a child node can be 
no smaller (in the case of minimization) than the objective 
65 value of its parent. 
If the linear program at a given node is solved and the 
optimal solution happens to have integral values for all the 
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relaxed binary variables, then this solution is feasible for the 
original 0/1 mixed integer program. Once a feasible solution 
for the original problem is found, the associated objective 
value can be used as an upper bound (in the case of 
minimization) for the objective values of LP's at other 
nodes. In particular, if an LP at another node is solved, and 
its objective value is greater than or equal to the upper 
bound, then none of its children could yield a feasible 
solution for the original MIP with a smaller objective value 
than the one already obtained. Hence, no further exploration 
of this other node is needed, and the node is said to be 
fathomed. 
14 
logic gates, a programmable gate array(s) (PGA), a field 
programmable gate array (FPGA), etc. 
The flowchart of FIG. 4 shows the functionality and 
operation of one implementation of system 11. Any process 
descriptions or blocks in flowcharts should be understood as 
representing modules, segments, or portions of code which 
include one or more executable instructions for implement-
ing specific logical functions or steps in the process, and 
alternate implementations are included within the scope of 
10 the preferred embodiment of the present invention in which 
functions may be executed out of order from that shown or 
discussed, including substantially concurrently or in reverse 
order, depending on the functionality involved, as would be Two other criteria for fathoming a node are apparent: if 
the associated LP is infeasible, or if the optimal solution of 
the LP has integral values for all relaxed binary variables, 15 
then no further exploration of the node is required. In the 
latter case, the optimal objective value of the LP will be 
compared with the current upper bound, and the upper 
bound will be updated if needed. The tree search ends when 
understood by those reasonably skilled in the art of the 
present invention. 
Referring to FIG. 4, at 34, information related to the 
prescribed dose is received. At 36, information related to 
target volume 20 is received. As described above, this 
information may include CT and/or MRI images identifying 
all nodes are fathomed. 
Although a variety of strategies may be used for intelli-
gently selecting branching variables and nodes to process, in 
the preferred embodiment, the branch-and-bound is coupled 
with other computational devices, such as problem prepro-
cessing, primal heuristics, global and local reduced-cost 
fixing, and cutting planes. 
In the preferred embodiment, global optimization module 
is based on a branch-and-bound MIP solver that is built on 
top of general-purpose mixed integer research code (MIP-
SOL). The general purpose code, which incorporates all of 
the above mentioned computational devices, has been 
shown to be effective in solving a wide variety of large-scale 
real-world MIP instances. 
System Implementation 
System 10 of FIG. 1 and system 11 of FIG. 2 can be 
implemented in hardware, software, firmware, or a combi-
nation thereof. FIG. 3 illustrates a preferred implementation 
of system 11. As described above, system 11 is similar to 
system 10 except for the inclusion of dose calculation 
module 26. Thus, although the preferred implementation is 
described below, system 10 is implemented in a similar 
fashion. 
As shown in FIG. 3, system 11 comprises computer 
processing unit (CPU) 28, memory 30, and local interface 
32. System 11 may communicate via local interface 32 with 
input devices and output devices. As shown in FIG. 2, input 
devices may include three-dimensional imaging system 16 
and/or input data 18 and output devices may include external 
beam delivery unit 12 and/or visual evaluation functionality 
14. 
Treatment plan modeling module 24, global optimization 
module 22, and dose calculation module 26 are implemented 
in software or firmware that is stored in memory 30 and 
executed by CPU 28. CPU 28 may be any suitable instruc-
tion execution system. It should be understood by persons 
skilled in the art that treatment plan modeling module 24, 
global optimization module 22, and dose calculation module 
26 may also implemented in hardware. For example, in 
accordance with the systems and methods of the present 
invention, treatment plan modeling module 24, global opti-
mization module 22, and dose calculation module 26 may be 
implemented with any or a combination of the following 
technologies, which are all well known in the art: a discrete 
logic circuit(s) having logic gates for implementing logic 
functions upon data signals, an application specific inte-
grated circuit (ASIC) having appropriate combinational 
20 the contours of target volume 20 and surrounding normal 
tissue and critical structures. Information related to external 
beam delivery unit 12, such as beam geometry and beam 
parameters, is received at 38. At 40, information related to 
the constraints to be incorporated into the treatment plan 
25 optimization model is received. For example, the treatment 
plan optimization model may incorporate dosimetric con-
straints and constraints on various characteristics of the 
beam arrangements. At 42, predefined clinical objectives are 
received. At 44, the variables to include in the treatment plan 
30 optimization model are determined. As described above, the 
present invention employs a global approach, and thus, all 
possible variables are included in the treatment plan opti-
mization model. At 46, the type of variable for each variable 
is determined, for example, whether the variable will be 
35 represented in the treatment plan optimization model as a 
non-negative continuous variable or a 0/1 integer variable. 
At 48, the treatment plan optimization model is determined 
by incorporating the variables, constraints, and the clinical 
objective into a global mathematical expression. At 50, a 
40 branch-and-bound algorithm is used to determine the opti-
mal treatment plan. 
Treatment plan modeling module 24, global optimization 
module 22, and dose calculation module 26, which comprise 
an ordered listing of executable instructions for implement-
45 ing logical functions, can be embodied in any computer-
readable medium for use by or in connection with CPU 28 
or any other instruction execution system, apparatus, or 
device, such as a computer-based system, processor-con-
taining system, or other system that can fetch the instruc-
50 tions from the instruction execution system, apparatus, or 
device and execute the instructions. In the context of this 
document, a "computer-readable medium" can be any 
means that can contain, store, communicate, propagate, or 
transport the program for use by or in connection with the 
55 instruction execution system, apparatus, or device. The 
computer-readable medium can be, for example but not 
limited to, an electronic, magnetic, optical, electromagnetic, 
infrared, or semiconductor system, apparatus, device, or 
propagation medium. More specific examples (a nonexhaus-
60 tive list) of the computer-readable medium would include 
the following: an electrical connection (electronic) having 
one or more wires, a portable computer diskette (magnetic), 
a random access memory (RAM) (electronic), a read-only 
memory (ROM) (electronic), an erasable programmable 
65 read-only memory (EPROM or Flash memory) (electronic), 
an optical fiber (optical), and a portable compact disc 
read-only memory (CDROM) (optical). Note that the com-
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puter-readable medium could even be paper or another 
suitable medium upon which the program is printed, as the 
program can be electronically captured, via for instance 
optical scanning of the paper or other medium, then com-
piled, interpreted or otherwise processed in a suitable man-
ner if necessary, and then stored in a computer memory. 
Intensity-Modulated Radiation Therapy (IMRT) Treatment 
Planning 
As described above, systems 10 and 11 may employ any 
type of external beam delivery unit and/or radiation modal-
ity (e.g. static conformal radiation therapy (SCRT), non-
coplanar arc stereotactic radiosurgery (NASR), intensity 
modulated radiation therapy (IMRT), intensity modulated 
arc therapy (IMAT), etc.). With reference to FIGS. 5-18, 
various exemplary embodiments of systems, methods, and 
computer programs will be described for implementing 
global optimization of IMRT treatment planning. These 
exemplary embodiments may include the components 
described above with respect to FIGS. 1-4 (e.g., global 
optimization module 22, treatment plan modeling module 
24, dose calculation module 26, etc.), and may operate in a 
similar manner. 
In IMRT, the beam intensity is varied across the treatment 
field. Rather than being treated with a single large, uniform 
beam, the patient is treated with many very small beams, 
each of which may be configured with a different intensity. 
Intensity modulation allows more intense treatment of the 
tumor, while limiting the radiation dose to adjacent healthy 
tissue. In the exemplary IMRT embodiments described 
below, the principles, operation, architecture, etc. of systems 
10 and 11 (FIGS. 1-4) may be used by incorporating the 
appropriate data variables, user input, constraints (e.g., dosi-
metric, beam geometry, etc.), clinical objectives, etc. to 
determine the corresponding treatment plan optimization 
model(s) and optimization mathematics, as well as deter-
mine the globally optimal solutions for the IMRT treatment 
plan. 
FIG. 5 illustrates a functional block diagram of one 
embodiment of an exemplary system 100 for providing 
global optimization of IMRT treatment planning. System 
100 comprises global optimization module 22, treatment 
plan modeling module 24, dose calculation module 26, input 
module 108, user interface 106, and image contour discreti-
zation module 110. As further illustrated in FIG. 5, system 
100 interfaces with various components, such as input/ 
output (I/O) devices 102, anatomical structures contouring 
module 104, 3-D imaging system 16, IMRT modality radia-
tion unit 112, and visual evaluation functionality 14. 
In general, global optimization module 22, treatment plan 
modeling module 24, and dose calculation module 26 are 
configured to operate as described above. Nonetheless, these 
and other components will be described in more detail 
below. As an initial matter, however, the components of 
system 100 will be briefly described, as well as the inter-
action between these components. In this regard, it should be 
appreciated that user interface 106, input module 108, and 
image contour discretization module 110 generally provide 
functionality to enable global optimization module 22, treat-
ment plan modeling module 24, and dose calculation mod-
ule 26 to interface with I/O devices 102, anatomical struc-
tures contouring module 104, and 3-D imaging system 16. In 
other words, user interface 106, input module 108, and 
image contour discretization module 110 provide an appro-
priate environment for receiving various types of data (e.g., 
from a user or physician, other hardware component, soft-
ware component, system, etc.) to be input to system 100. As 
16 
described above, this and other data may be used to generate 
treatment plan optimization model(s) (treatment plan mod-
eling module 24), define appropriate mathematics, variables, 
etc. for global optimization module 22, and/or perform a 
dose calculation (dose calculation module 26). 
Referring again to FIG. 5, image contour discretization 
module 110 interfaces with dose calculation module 26, 
IMRT modality radiation unit 112, anatomical structures 
contouring module 104, and 3-D imaging system 16. In 
10 general, image contour discretization module 110 receives 
data related to the location of a target volume, surrounding 
critical structures, etc. from anatomical structures contour-
ing module 104 and 3-D imaging system 16. Image contour 
discretization module 110 may also receive data input from 
15 IMRT modality radiation unit 112. As described in more 
detail below, the data received by image contour discreti-
zation module 110 may be processed and provided as input 
to dose calculation module 26. Furthermore, the output of 
the dose calculation module 26 is provided to treatment plan 
20 modeling module 24. 
User interface 106 and input module 108 provide a 
suitable environment that enables a physician, system opera-
tor, etc. ("user") to provide various types of data to system 
100 via I/O devices 102. For example, input module 108 
25 interfaces with global optimization module 22 and treatment 
plan modeling module 24. In this regard, input module 108 
may be configured to support interactive communication 
between the user and global optimization module 22 and 
treatment plan modeling module 24 (via user interface 106 
30 and I/O devices 102). As described above and below in more 
detail, input module 108 may enable the user to input 
various types of criteria of interest for the treatment plan 
optimization model and the corresponding optimization 
mathematics (e.g., prescribed radiation dose, constraints, 
35 clinical objectives, variables to include in treatment plan 
optimization model, variable types, couch angles, field size, 
LAO gantry angle for each field, etc.). 
System 100 may also comprise visual evaluation func-
tionality 14. Visual evaluation functionality 14 enables the 
40 user to preview a particular IMRT treatment plan provided 
by treatment plan modeling module 24. Visual evaluation 
functionality 14 may also be used to enable the user to verify 
data that has been input to system 100 via input module 108, 
anatomical structures contouring module 104, 3-D imaging 
45 system 16, and IMRT modality unit 112. For example, ifthe 
data being previewed is incorrect, or simply undesirable, the 
user may edit the input data as desired. It should be 
appreciated that visual evaluation functionality 14 and I/O 
devices 102 may be integrated. In other words, visual 
50 evaluation functionality 14 may be integrated with user 
interface 106 to provide a visual display for the user. 
As further illustrated in FIG. 5, treatment plan modeling 
module 24 also interfaces with global optimization module 
22. The operation, architecture, and functionality of global 
55 optimization module 22, treatment plan modeling module 
24, and dose calculation module 26 are generally described 
above. Furthermore, various exemplary IMRT embodiments 
of these modules are described below. However, in terms of 
the general operation of system 100, it should be appreciated 
60 that global optimization module 22 determines an optimal 
solution to the global mathematical expression defined by 
the treatment plan optimization model(s) generated by treat-
ment plan modeling module 24. The optimal solution, which 
defines a globally optimal treatment plan, may be executed 
65 on target volume 20 by IMRT radiation modality unit 112. 
Having generally described the components of system 
100 and their interaction, various implementations of input 
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module 108, image contour discretization module 110, glo-
bal optimization module 22, treatment plan modeling mod-
ule 24, and dose calculation module 26 will be described 
relative to FIGS. 6-18. 
As mentioned above, a user may interface with system 
100 via various types of I/O devices 102 in communication 
with user interface 106, input module 108, etc. At various 
stages in the development of the treatment plan optimization 
model(s) and the optimal treatment plan, system 100 may 
require input from the user. In this regard, user interface 106 
may be configured in a number of ways. For instance, FIG. 
6 is a screen shot illustrating one of a number of embodi-
ments of a user interface 106 configured to enable the user 
to provide input to system 100 via input module 108. The 
embodiment of FIG. 6 supports a graphical user interface 
(GUI) environment. It should be appreciated that alternative 
designs may be employed, such as a command-based inter-
face and others. 
FIG. 6 is an example of a user input screen 114 supported 
by a graphical user interface for enabling a user to input 
various types of input data. In the embodiment illustrated in 
FIG. 7, user interface 106 provides a window 116 in which 
a user may input, for example, the number of fields (beams), 
the couch angle, the dimensions of each field in terms of an 
array of beamlets (e.g., 30x30), and the LAO gantry angle 
for each field to be used for the IMRT treatment plan. This 
data and other types of data may be used to develop the 
treatment plan optimization module, which is used by global 
optimization module 22 to develop a globally optimal IMRT 
treatment plan. 
FIG. 7 is another embodiment of a user input screen 122 
supported by user interface 106, which enables a physician 
to input various additional types of data to system 100. As 
illustrated in FIG. 7, user input screen 122 may comprise a 
window 124 in which the physician may specify various 
data related to the anatomical structures associated with 
target volume 20. In the embodiment of FIG. 7, the physi-
cian has specified various regions within the target volume 
20 (e.g., a "tumor" region, a "critical structures" region, and 
18 
prescription data, dose volume constraints, clinical objec-
tives, and physical constraints. For a given structure, the 
dose-volume histogram (DVH) is a graph which plots as a 
function of dose, D, the probability that a randomly-selected 
voxel volume receives a dose of at least D. This information 
can be incorporated within the treatment planning optimi-
zation using the dose volume constraints. Many clinical 
objectives (e.g., maximizing mean dose to target, minimiz-
ing radiation to critical structures, etc.) can be input in this 
10 module by the clinician, or the user. The physical constraints 
describe the number of beams and physical parameters the 
user would prefer in the resulting treatment plan. 
It should be appreciated that system 100 may receive a 
variety of alternative data inputs via user input screens 
15 supported by user interface 106. As described above in 
detail, systems 10, 11, and 100 may use any of the following, 
or other, types of information as input to dose calculation 
module 26, treatment plan optimization module 24, and 
global optimization module 22: information related to the 
20 prescribed radiation dose; information related to the target 
volume (e.g., spatial orientation of target volume, surround-
ing normal tissue, proximal critical structures, etc.); infor-
mation related to external beam delivery unit 12 (e.g., # of 
beams, couch angle, field size, etc.); information related to 
25 constraints to be incorporated into the treatment plan opti-
mization model (e.g., dosimetric constraints, beam geometry 
and parameter constraints, etc.); clinical objectives; other 
variables to include in treatment plan optimization model; 
and type of variable (e.g., non-negative continuous, 0/1 
30 integer, etc.). This data may also be used to develop the 
treatment plan optimization model(s) or to configure the 
dose calculation module or global optimization module 22. 
Referring to FIGS. 9-18, the architecture, operation, 
and/or functionality of various embodiments of dose calcu-
35 lation module 26, treatment plan optimization module 24, 
and global optimization module 22 will be described. FIG. 
9 is a flow chart illustrating various data inputs to an 
embodiment of dose calculation module 26 for IMRT treat-
a "normal tissue" region). User input screen 122 enables the 40 
physician to specify the corresponding anatomical structures 
for each of these regions (i.e., prostate, rectum and bladder, 
and skin). As illustrated in FIG. 7, user interface 106 may 
provide text boxes (shaded boxes in FIG. 7) for inputting the 
data. User input screen 122 further enables the physician to 45 
select the structures and specify the prescription dose, and 
the lower and upper bound factors for the corresponding 
anatomical structures. The physician may also specify the 
following, and other, types of information: tumor coverage, 
homogeneity, number of input candidate beams, and number 50 
of output beams. Any of these, and other, types of data may 
ment planning. In the embodiment illustrated in FIG. 9, dose 
calculation module 26 interfaces with image contour dis-
cretization module 110, treatment plan modeling module 24, 
and IMRT modality radiation unit. As described above with 
respect to FIGS. 5--8, image contour discretization module 
110 may receive various types of information from 3-D 
image system 16, anatomical structures contouring module 
104, and a field setup module 134. For example, image 
contour discretization module 110 may receive any of the 
following, or other, types of data: CT/MR scans with tumor 
and critical structures outlined by the clinician; number, 
direction and angle of beams in the IMRT modality radiation 
unit 112, etc. In certain embodiments, image contour dis-
be used to develop the treatment plan optimization model(s). 
As known in the art, prescription dose refers to the radiation 
dose the clinician prescribed to the tumor target. Lower and 
upper bound factors correspond to the fraction of prescribed 55 
dose that can be tolerated by various anatomical structures. 
These dose limits are represented with respect to the pre-
scribed dose. Coverage refers to the percentage of tumor 
volume receiving the prescribed dose, and homogeneity 
indicates the ratio of the maximum dose to the tumor to the 60 
minimum dose to the tumor. 
FIG. 8 illustrates a further embodiment of a user input 
screen 126 supported by user interface 106, which enables 
a physician to input various types of data related to the 
radiation doses for the anatomical structures specified in 65 
FIG. 7. In the embodiment illustrated in FIG. 8, user input 
screen 126 enables the physician to specify data related to 
cretization module 110 may superimpose image registration 
data from the 3-D image system 16 and anatomical struc-
tures contouring module 104 and provide image contour 
discretization data 130 and candidate fields data 132 to dose 
calculation module 26. As known in the art, various types of 
data from radiation unit 112 may also be provided to dose 
calculation module 26 via interface 131. As described above 
in detail, dose calculation module 26 may use standard dose 
calculation tools to calculate, for each voxel, the dose 
contribution per monitor unit of radiation from each beamlet 
in each field. 
FIG. 10 is a flow chart illustrating the general architec-
ture, operation, and/functionality of an embodiment of treat-
ment plan modeling module 24. In the embodiment of FIG. 
10, treatment plan modeling module 24 comprises a verifi-
cation algorithm module 133, a model file 134, a treatment 
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planning algoritlnn module 136, and a mathematical formu-
lation module 138. As illustrated in FIG. 10, all relevant 
input data from dose calculation module 26 and I/O devices 
102 is provided to verification algoritlnn module 133. The 
architecture, operation, and functionality of an embodiment 
of verification algoritlnn 133 is described below in detail 
with reference to FIG. 11. Verification algoritlnn module 133 
outputs data to a model file 134. Model file 134 contains all 
20 
dose, and clinical information. At block 158 verification 
algoritlnn module 132 outputs model file 134. Verification 
algoritlnn module 132 terminates at block 160. 
FIG. 12 is a flow chart illustrating the architecture, 
operation, and/or functionality of an embodiment of treat-
ment planning algoritlnn module 136. After beginning at 
block 162, at block 164, treatment planning algoritlnn 
module 136 opens a patient data file. The patient data file 
corresponds to the data file output 158 (FIG. 11) by verifi-
cation algoritlnn module 133. In general, it comprises all 
image voxels and dose and clinical information for modeling 
purposes. At block 166, treatment planning algoritlnn mod-
ule 136 reads in model file 134 used for the patient. At block 
168, treatment plarming algoritlnn module 136 sets up 
variables for the treatment plan optimization model. At 
block 170, treatment planning algoritlnn module 136 sets up 
a clinical objective for the treatment plan. It should be 
appreciated that the objective may be defined according to 
the clinical setting, patient, treatment, etc. For example, the 
of the data to be used to define the global mathematical 
expression for the treatment plan optimization model. The 10 
user may view data from model file 134 on visual evaluation 
functionality 14. Data from model file 134 is input into a 
treatment planning algoritlnn module 136. The architecture, 
operation, and functionality of an embodiment of treatment 
planning algoritlnn module 136 is described below in detail 15 
with reference to FIG. 12. Treatment planning algoritlnn 
module 136 sends data to mathematical formulation module 
138 to determine the global mathematical expression to be 
optimized by global optimization module 22. At various 
points in this process, treatment modeling module 24 may 
provide outputs to visual evaluation functionality 14, from 
which the user may verify and either accept or modify 
through I/O devices 102. After a treatment plan optimization 
model is generated, the global mathematical expression is 
provided to global optimization module 22. 
20 clinical objective may include maximizing mean tumor 
dose, minimizing total dose to critical structures, maximiz-
ing dose falloff outside tumor volume, etc. It should be 
further appreciated that the clinical objective may be 
extracted from model file 134. The clinical objective may be 
FIG. 11 is a flow chart illustrating the architecture, 
operation, and functionality of an embodiment of verifica-
tion algoritlnn module 133. After beginning at block 140, 
verification algoritlnn module 133 may open an image data 
file from dose calculation module 26 at block 142. The 
image data comprises the structures that will be used for 
modeling the treatment plans, the number of voxels dis-
cretized for each structure, the number of candidate beams 
generated, and the associated dose contribution per monitor 
unit to each voxel (of each structure) from each beamlet 
generated from the set of all candidate beams. Verification 
algoritlnn module 133 will check that this data is consistent 
and the dose for each voxel and each beamlet is registered 
25 used to drive the search process (for an optimal treatment 
plan) in the optimization process. At block 172, treatment 
planning algoritlnn module 136 sets up the specified con-
straints (e.g., physical constraints, dose constraints, etc.) for 
the treatment plan optimization model. At block 174, treat-
30 ment planning algoritlnn module 136 sets up the specified 
constraints for beam geometry. At block 178, treatment 
planning algoritlnn module 136 defines a global mathemati-
cal expression based on model file 134, relevant variables, 
the specified clinical objective(s) and constraint(s), etc. This 
35 global mathematical expression defines the treatment plan 
optimization model. It should be appreciated that other 
variables may be incorporated in the model as desired for 
IMRT treatment planning. At block 178, treatment planning 
algoritlnn module 136 may store the treatment plan optimi-in the file, and compile all this data into a single file for 
modeling purposes. At block 144, verification algoritlnn 
module 133 may process the data into an array. At block 146, 
verification algoritlnn module 133 opens a clinical and beam 
data file containing information regarding clinical proper-
ties, beam properties, etc. The clinical beam and data file(s) 
contain the prescription dose, dose bounds, dose volume 45 
restrictions for each structure, clinical metrics (e.g. cover-
age, conformity, homogeneity) for the target volume, and 
physical beam profile for input and output purposes (e.g. the 
total number of candidate beams used for setting up the 
treatment models, and the desired number of output beams 50 
for treating the patients). At block 148, verification algo-
ritlnn module 133 may process this data into another array. 
40 zation model, and, at block 180, treatment planning algo-
ritlnn module 136 ends. 
FIG. 13 is a functional block diagram illustrating an 
embodiment of model file 134. As described above with 
regard to FIG. 10, verification algoritlnn module 133 may 
output model file 134 to a user. Referring to FIG. 13, model 
file 134 may comprise two formats. For example, model file 
134 may be presented in a format suitable for display to the 
user via visual evaluation functionality 14 (user display 
format 182). Model file 134 may also comprise a format 
suitable for mathematical expression (format 184). The 
reason for these two formats is that the user generally lacks 
the technical expertise to comprehend model file 134 in the 
mathematics expression format 184. Furthermore, math-
ematics expression format 184 may contain data not relevant 
to the user's needs. System 100, therefore, may output data 
in a form most beneficial to the user. Model file 134 is 
provided to treatment plarming algoritlnn 136. 
FIG. 14 is a functional block diagram illustrating the 
architecture, operation, and/or functionality of an embodi-
ment of global optimization module 22 for IMRT treatment 
planning. As described above, treatment plan modeling 
module 24 outputs the treatment plan optimization model(s) 
to global optimization module 22. The embodiment of 
global optimization module 22 illustrated in FIG. 14 com-
At decision block 150, verification algoritlnn module 133 
performs a validity check to determine whether the data in 
the arrays is valid. If the data is not valid, at block 152, an 55 
output error is provided to the user and the user may proceed 
with another file, edit the file, etc. (block 154). The validity 
check may be configured to determine, for example, whether 
the number of beams (fields) is consistent in all files, 
whether there are missing dose values for any voxel, 60 
whether the prescription dose is given, whether the dose 
level is consistent and feasible, whether all the input for the 
anatomical structures is accounted for, and whether the 
biological and clinical factors are well defined, to name a 
few. 65 prises includes two components: optimization module 190 
and post-optimization validation module 192. Optimization 
module 190 determines the most optimal solution within the 
If the data is valid, at block 156, verification algoritlnn 
module 133 outputs a data file which contains all image, 
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solution space for the treatment plan optimization model, 
and sends the output solution to post-optimization validation 
module 192. Post-optimization validation module 192 cal-
culates various forms of statistical data related to the optimal 
treatment plan, and sends that data to visual evaluation 
functionality 14. 
FIG. 15 illustrates the architecture, operation, and/or 
functionality of an embodiment of post-optimization vali-
dation module 192. As illustrated in FIG. 15, optimization 
module 190 outputs the globally optimal treatment plan into 10 
post-optimization validation module 192. The internal com-
ponents of post-optimization module 192 may comprise, for 
example, dose distribution calculation module 202, clinical 
metrics module 204, and dose volume histogram analysis 
module 206. Dose distribution calculation module 202 cal- 15 
22 
selection plan or re-model 224. The isodose curves tool 212 
describes the contour of dose level for each structure. The 
homogeneity, coverage and conformity tools 214, 216, and 
218 describe the dose distribution, tumor coverage and 
tightness of prescription isodose curves to the tumor vol-
ume. The tumor control biological modeling tool 222 cal-
culates the tumor control probability and normal tissue 
complication probability values associated with the globally 
optimal treatment plan. The mean dose (max/min) tool 220 
provides dose distribution statistics for the tumor and other 
anatomical structures associated with the globally optimal 
treatment plan. If the user determines this is data reflects a 
suitable treatment plan, the user may send a command to 
initiate the globally optimal treatment plan (i.e., implement 
the treatment plan on the patient). If the user determines that 
the data displayed on the visual evaluation functionality 
does not reflect a suitable treatment plan, the user may edit 
the treatment plan as desired or configure a new treatment 
plan optimization model, enter new data, and determine new 
culates the dose to be distributed to various parts (e.g., 
anatomical structures) of the patient related to the globally 
optimal plan. Clinical metrics module 204 may be config-
ured to provide various visual tools (e.g., coverage, homo-
geneity, conformity, D95 , the dose level which covers 95% 20 globally optimal treatment plan. 
of tumor target, V 20, the volume receiving more than 20 Gy, 
etc.) related to the globally optimal treatment plan. As the 
name suggests, dose volume histogram analysis module 186 
may generate and display a dose volume histogram for the 
globally optimal treatment plan and display it on visual 25 
evaluation functionality 14. 
It should be appreciated that global optimization module 
22 may include any type of module(s) for enabling the user 
With FIGS. 5-18 and the corresponding text as a back-
drop, a further embodiment of a treatment plan optimization 
model and global optimization module 22 will be described, 
which incorporates a mixed integer programming approach. 
As detailed above, for intensity-modulated radiation 
therapy (IMRT), the shape of the beams, and the combina-
tions of open and closed MLC leaves control and modulate 
the intensity. This may provide the ability to dynamically 
vary the dose to accommodate the shape of the tumor from to view, assess, etc. the globally optimal treatment plan 
generated by optimization module 190. For example, FIG. 
16 is a screenshot illustrating one embodiment of a visual 
tool-an intensity map of target volume 20. As a non-
limiting example, FIG. 16 illustrates the various beamlet 
intensities of four different fields of IMRT radiation modal-
30 different angles so as to deliver full tumoricidal dose, while 
normal tissue is spared from excess radiation. 
In the IMRT optimization schemes employed in systems 
10, 11, and 100, photon fluence from a beam may be 
subdivided into "beamlets," which may be imagined to be 
ity unit 112. In this particular example, each field includes a 
20x20 array ofbeamlets. FIG. 16 further illustrates that each 
field has different beamlet intensities, and that no field is 
dependent on any other field. The scale to the right of each 
intensity diagram in FIG. 16 illustrates that the dark shading 
represents higher intensity, while the lighter shading repre-
sents lower intensity. As stated above with respect to FIG. 6, 
each field has a gantry angle and a diversity of beamlet 
intensities converging at, or around, target volume 20, which 
may result in various shapes of treatment dose to better 
conform to target volume 20. 
35 divergent rectangular solids of fluence emanating from a 
radiation source in the treatment head of the linear accel-
erator (LINAC). One dimension of these beamlets, call it the 
"height," is defined by the projection of the MLC leaves 
onto a plane that is perpendicular to the central axis of the 
40 LINAC's beam and located at the rotational isocenter of the 
45 
While FIG. 16 illustrates beamlet intensities graphically, 
FIG. 17 illustrates the values numerically. FIG. 17 is an 
example of another visual tool for displaying beamlet inten-
sities of IMRT radiation modality unit 112. This particular 
embodiment illustrates a field with 400 beamlets, which is 50 
organized in a 20x20 configuration. As shown in FIG. 17, 
the intensities of each beamlet can vary substantially, and are 
not constrained by other beamlets in the array. 
As mentioned above, in developing and reviewing the 
globally optimal treatment plan, various data may be perti- 55 
nent to the user. This data may be displayed on visual 
evaluation functionality 14. In this regard, FIG. 18 is a block 
diagram illustrating various other visual tools, resources, 
etc. that may be provided to the user. As shown in FIG. 18, 
these tools may be integrated with visual evaluation func- 60 
tionality 14 to enable the user to view various aspects of the 
globally optimal treatment plan before it is implemented on 
the patient. For example, system 100 may support any of the 
following, or other, types of tools: dose volume history tool 
210, isodose curves tool 212, homogeneity tool 214, mean 65 
dose (max/min) tool 220, conformity tool 218, coverage tool 
216, tumor control biological modeling tool 222, and final 
LINAC. These height projections may be between 0.5 and 
1.0 cm. In the "width" direction the resolution of the beamlet 
(projected on the same plane) may be between 0.2 and 1.0 
cm. 
In treatment plan modeling module 24 and global opti-
mization module 22, optimization may be performed over 
beamlets, rather than "beam segments" or "field segments," 
which are collections ofbeamlets that have been set to have 
the same intensity. The use of field segments may be 
advantageous for two reasons: (1) aggregations of many 
very small field dose calculations (i.e., on the order of a 
single beamlet) may be difficult; and (2) treatment time is 
proportional to the number of fields delivered. For reasons 
of economy and patient comfort, treatment times may be 
kept short. 
Radiation dose, measured in Gray (Gy), is energy (Joules) 
deposited locally per unit mass (Kg). Fluence for external 
beam photon radiation may be defined mathematically by 
the number of photon crossings per surface area. Dose tends 
to be proportional to fluence, but is influenced by photon and 
electron scatter in the patient's tissues as well as the energy 
and media involved. For any beam, selection of beamlet 
fluence weights results in a "fluence map" (intensity map) 
for that beam. 
As described below, global optimization module 22 and 
treatment plan modeling module 24 may be configured to 
optimize each of the following beam delivery parameters: 
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beamlet fluence weights, most current optimization algo-
rithms for IMRT treatment planning search the space of 
beamlet fluence weights only. By way of additional back-
ground, the planning process begins when the patient is 
diagnosed with a tumor mass and radiation is selected as part 
of the treatment regime. A 3D image, or volumetric studyset, 
of the affected region, which contains the tumor mass and 
the surrounding areas, is acquired via 3D imaging system 16 
(e.g., computed tomography (CT) scans). This CT data is 
used for treatment planning, and electron density informa- 10 
tion derived from it is used in the photon dose calculations 
for the beamlets. Additionally, magnetic resonance imaging 
(MRI) scans may be acquired, fused with the CR volumetric 
studyset, and used to identify the location and extents of 
some tumors-especially those in the brain. Based on these 15 
scans, the physician outlines the tumor and anatomic struc-
tures that need to be held to a low dose during treatment. 
24 
deposited from each beamlet. For each patient, 16 non-
coplanar candidate fields are generated. The size of the 
candidate fields and the associated number of beamlets is 
patient and tumor size dependent; varying from lOxlO cm2 
with 400 beamlets per field to 15x15 cm2 with 900 beamlets 
per field. This results in a large set of candidate beamlets 
used for instantiating the treatment plan optimization model. 
Treatment plan modeling module 24 and global optimi-
zation module 22 may employ the following mixed integer 
programming approach. Let B denote the set of candidate 
means, and let N, denote the set ofbeamlets associated with 
beam iEB. Beamlets associated with a beam can only be 
used when the beam is chosen to be "on." If a beam is on, 
the beamlets with positive dose intensity will contribute a 
certain amount of radiation dosage to each voxel in the target 
volume and other anatomical structures. Once the set of 
potential beamlet intensities is specified, the total radiation 
20 dose received at each voxel can be modeled. Let wif~O 
denote the intensity ofbeamletj from beam i. Then the total 
radiation dose at a voxel P is given by the following 
Typically, several regions of the tissue to be treated are 
identified. The gross target volume (GTV) represents the 
volume which encompasses the known macroscopic dis-
ease; that is, the disease that can be seen by the oncologist. 
The clinical target volume (CTV) expands the GTV to 
include regions of suspected microscopic disease. The plan-
ning target volume (PTV) includes additional margins for 
25 
anatomical and patient setup uncertainties; that is, how the 
patient's organs and the patient will move from day to day. 
All volumetric data is discretized into voxels (volume ele-
ments) at a granularity that is conducive both to generating 
a realistic treatment plan optimization model and to ensuring 30 
that the resulting treatment planning integer progranmiing 
instances are tractable (i.e., capable of being solved in a 
reasonable amount of computational time). 
expression: 
Equation 8 
where DP.if denotes the dose per intensity contribution to 
voxel P from beamlet j in beam i. Various dose constraints 
are involved in the design of treatment plans. Clinically 
prescribed lower and upper bounds, say Lp and Up, for dose 
35 
at voxel Pare incorporated with Equation 8 to form the basic 
dosimetric constraints: 
Dose calculation module 26 may involve the principle of 
convolving the total energy release in the patient from the 
radiation source with Monte Carlo-generated energy dispo-
sition kernels and superposition of pencil beam (SPPB) 
using fundamental physics describing photon and electron 
interactions and transport. Dose calculation module 26 may 40 
account for the transport of primary and secondary radiation 
inside the patient, the variation of beam intensity across the 
patient surface, the effects of tissue inhomogeneities on the 
dose, and the irregular blocked or multi-leaf (MLC) shaped 
fields. Dose calculation module 26 may comprise the fol-
lowing three components for computing the 3D dose distri-
bution: 
Equation 9 
Aside from constraining the dose received by each voxel 
within anatomic structures, treatment plan modeling module 
Modeling the incident energy fluence as it exits the head 
of the linear accelerator. 
45 
24 may constrain the number of beams used in the final 
beam profile. The motivation for this is that a simple plan 
(with a relatively small number of beams) may be preferred 
by a physician over a more complex plan, since a complex 
plan takes more time to implement in the delivery room and 
Projection of this incident fluence through the density 
representation of a patient to compute a Total Energy 
Released per unit MAss (TERMA) volume. 
50 offers more chances for errors. Let x, be a binary variable 
denoting the use or non-use of beam i. The following 
constraints limit the total number of beams used in the final 
A three-dimensional superposition of the TERMA with an 
energy deposition kernel using a ray-tracing technique 55 
to incorporate the effects of heterogeneities on lateral 
scatter. 
Dose calculation module 26 may compute the dose to 
points, D(r). The dose at point D(r) comprises contributions 
from the shower of secondary particles resulting from pri- 60 
mary interactions at radii r'. The SPPB model provides 
accurate results within areas of electronic disequilibrium and 
tissue heterogeneities. 
For each beamlet, the dose per intensity to a voxel is 65 
calculated using this dose engine. The total dose per inten-
sity deposited to a voxel is equal to the sum of dose 
plan and ensure that beamlet intensities are zero for beams 
not chosen: 
Wij ::; MjXj and 2= Xj ::; Bmax 
iEB 
Equation 10 
Here, M, is a positive constant which can be chosen as the 
largest possible intensity emitted from beam I, and Bmax is 
the maximum number of beams desired in an optimal plan. 
Dose-volume relationships within different anatomical 
structures are set up based on these constraints. Clinically, it 
is typically acceptable when 95% of the PTV receives the 
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prescription dose, PrDose. The coverage constraints for PTV 
can be modeled as: 
1= 1= DP,uwu - rp = PrDose, PE PTV 
iEj3 iENj 
Equation 11 5 
26 
The MIP instances include the basic dosimetric and 
volumetric constraints as described in Equations 10-18 in 
addition to other clinical constraints. The resulting MIP 
instances have at least ~,cslN,1+1+3(1PTVl+l)+~,EolKI 
(210AR,I+ 1 )+(IKl-1 )IOAR,I constraints; ~,cslN,l+IPTVI con-
tinuous variables; and IBl+IPTVl+~,Eo21KllOAR,I binary vari-
ables, where 0 is the set of all organs-at-risk and normal 
structures. For real patient cases, there are tens of thousands 




have proven to be computationally very difficult for com-
petitive commercial MIP solvers. Following, a few special-
ized techniques that may be implemented in treatment plan 
modeling module 24 are described. 
Equation 14 1= Vp <: a:IPTVI 
PEPTV 
Here, Vp is a 0/1 variable which captures whether voxel P 
satisfies the prescription dose bounds or not; rp is a real-
valued variable that measures the discrepancy between 
prescription dose and actual dose; a corresponds to the 
minimum percentage of coverage required (e.g., a=0.95); 
Dprvon and Dprvun are the maximum overdose and maxi-
mum underdose levels tolerated for tumor cells; and IPTVI 
represents the total number of voxels used to represent the 25 
planning target volume. The values DPrvon and DPrvun 
may be chosen with care to provide a feasible system of 
constraints. 
To maintain a tractable linear program relaxation, at a 
node of the branch-and-bound tree, instead of setting up the 
15 entire problem instance using all the voxel information, a 
master problem which consists of roughly half of the origi-
nal voxels may be generated. This subset is selected care-
fully in order to maintain a realistic description of the 
problem. As the solution process proceeds, additional voxels 
20 are introduced. This leads to the addition of constraints and 
the corresponding columns (variables). Constraints which 
have remained inactive for a specified number of LP solves 
are removed from the master problem, thus providing a 
mechanism for controlling the size of the master instance. 
For the constraint ~,EBx,Bmax which bounds the number 
of beams (gantry angles and directions) selected in the final 
plan, instead of branching on each binary variable with 
fractional value, global optimization module 22 branches on 
sets of binary variables. In particular, let xLP be the fractional 
30 solution. The branching scheme partitions B into B1 U B2 
such that ~,cs1 x/P approximately equals ~,cs2x/F. In addi-
tion, an attempt is made to choose each set B, so that the 
included beams are roughly in the neighborhood of each 
other. Two new nodes are then created via the constraints 
It may be desirable that dose received by organs/tissues 
other than the tumor volume be minimal, as there is a direct 
correlation between the level or radiation exposure and 
normal tissue toxicity. Thus, for other anatomical structures 
involved in the planning process, along with the basic dose 
constraints given in Equation 9 additional binary variables 
are employed for modeling the dose-volume relationship. 35 
The dose-volume relationship is a standard metric that 
clinicians use when assessing a plan. It is a quantitative 
measure of the percentage volume of the anatomical struc-
ture receiving dose within specified intervals. To incorporate 
this concept into the model, let ak, ~kE(O,l) fork in some 
40 
index set K, and let y P a.k and Zp a.k be binary variables. Then 
the following set of constraints ensures that at least 100~k% 
of the voxels in an organ-at-risk, OAR, receive dose less 
than or equal to ak PrDose. In treatment plan modeling 
module 24 and global optimization module 22, the cardi-
nality of the index set K is between 3 and 10. 
Equation 15 
PE OAR 






The heuristic procedure is an LP-based primal heuristic in 
which at each iteration, some binary variables are set to 1 
and the corresponding linear program is resolved. The 
procedure terminates when the linear program returns an 
integer feasible solution or when it is infeasible. In the 
50 
former case, reduced-cost fixing is performed at the root 
node, as well as locally on each of the branch-and-bound 
nodes. 
55 
The heuristic procedure focuses on the binary variables 
Equation 19 
from the constraints in Equations 12-18. Given a fractional 
solution obtained from an LP relaxation at a node, let 
U={j:Cl/LF =1 }, F={j:O<ClJLF <1 }, and qmax=max {'lJLF:jEF}. 
Here, Dmax is the maximum dose tolerance allowed for 
OAR, and ak, ~k combinations are patient and tumor spe- 60 
cific. 
The heuristic works by first setting all binary variables in U 
to 1. Next, any variable in F for which the fractional value 
exceeds qmax_E is set to 1, where E is a real number 
There are many objective functions that can be used to 
drive the optimization engine. For the computational work 
in this example, the objective was to minimize a weighted 
sum of the excess dose to the PTV and the total dose to 
organs-at-risk. Of course, other objectives may be 
employed. 
between 0 and 0.2 and is dynamically chosen with each 
fractional LP solution. Finally, it sets to 1 any variable 
corresponding to a voxel that is in a specified neighborhood 
65 of a voxel for which the associated binary variable was 
already set to 1 in the previous two steps. The final step is 
based on the premise that if a voxel satisfies a certain dose 
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bound, then all voxels in its neighborhood should also 
satisfy the dose bound. The implementation involves a 
one-to-one mapping between the variables and the geomet-
ric locations of the associated voxels in a fixed 3D coordi-
nate system. 
As known in the art, a disjunctive argument may be used 
to develop valid inequalities for mixed integer programs. 
Disjunctive cuts have the appeal that they can be applied to 
general integer programs without requiring any knowledge 
of the facial structure of the underlying polyhedron. Below, 
one implementation of a disjunctive approach is described. 
Consider the polyhedron 
Equation 20 
where Ax~B includes Ax b and the restrictions xj 1 for 
j=l, ... p; AEmmxn. Let x'Em+n be a feasible solution of 
Ax~ B such that O<x,' < 1 for some i E{ 1, ... , p} and consider 
the pair of polyhedra 
Px;,o ~{ xE!R+ n:Ax~ 8,x;~O} 
28 
tive problem. In this exemplary implementatiol}, 11~11 1 ~1(1 1 
norm) is used as the bounding condition for a. This cut-
generation procedure may be performed at the root node, as 
well as at tree levels that are a multiple of 10 within the 
branch-and-bound tree. To avoid excessive computational 
time, we select pseudo-randomly only 10% of the fractional 
variables for cut generation. 
It should be emphasized that the above-described embodi-
ments of the present invention, particularly, any "preferred" 
10 
embodiments, are merely possible examples of implemen-
tations, merely set forth for a clear understanding of the 
principles of the invention. Many variations and modifica-
tions may be made to the above-described embodiments of 
the invention without departing substantially from the spirit 
and principles of the invention. All such modifications and 
15 variations are intended to be included herein within the 
scope of this disclosure and the present invention and 
protected by the following claims. 
The invention claimed is: 
Equation 21 20 1. A method for developing an optimal treatment plan for 
treatment of a target volume within a patient using an 
external beam radiation delivery unit, the method compris-
ing: 
Clearly PIP::::iPx;=conv(Px;t.aUPx;. 1). Assume that both Px;.o 
and P x;. 1 are nonempty (otherwise, x, can be eliminated). The 
following fact, which is motivated by results in Balas [ 4], 
forms the basis of our cut-generation procedure. 25 
For example, the system defined by Equations 22-28 is 
infeasible if, and only if, x'@x;· 
Ay-By00 Equation 22 
Az-6z00 Equation 23 
zi-z0 =0 Equation 24 
Y;~O Equation 25 
zo+Yo~l Equation 26 
z+y=xt Equation 27 
y,z,y0 ,z0 0 Equation 28 
This, together with Gale's Theorem of the Alternative, 
implies that x'EfP x if, and only if, the following linear system 
(Equations 29-34) is feasible: 
a+i)Tx'<O Equation 29 
u 1 TA+u4ei+j)TI~O Equation 30 
u2TA+u3ei+j)TI~O Equation 31 
-u 1 Tb+a~0 Equation 32 
-U2Tb-u3+a~O Equation 33 







where u1 , u2Em"', ~E!Rn, and u3 , u4 , aEm. From the latter 
system, form a linear program by (a) removing the first 
inequality and embedding it into the objective: min 
{a+Vx'},_and (b) enforcing an appropriate bounding con-
dition on a. Such a linear program will be referred to as a 60 
disjunctive LP. If the optimal objective value of a disjunctive 
LP is negative, then the inequality ~rx~-a is a valid 
inequality for P x which cuts off the fractional solution x'. 
receiving information corresponding to at least one 
parameter related to intensity-modulated radiation 
therapy (IMRT) to be used in developing the optimal 
treatment plan; 
receiving information corresponding to at least one clini-
cal objective related to a target volume and a critical 
structure; 
developing a treatment plan optimization model based on 
a plurality of variables corresponding to the at least one 
parameter related to IMRT and the at least one clinical 
objective which define a global system; and 
developing a globally optimal treatment plan which opti-
mizes the at least one clinical objective subject to the at 
least one parameter. 
2. The method of claim 1, further comprising providing a 
visual tool for enabling a user to evaluate the globally 
optimal treatment plan. 
3. The method of claim 2, wherein the providing a visual 
tool comprises providing an isodose curve corresponding to 
the globally optimal treatment plan. 
4. The method of claim 2, wherein the providing a visual 
tool comprises providing at least one of a dose-volume 
histogram, a coverage index, a conformity index, a homo-
geneity index, a tumor control and normal tissue complica-
tion probability index, and a display of clinical metrics to the 
user. 
5. The method of claim 1, wherein the receiving the 
information corresponding to at least one parameter related 
to IMRT comprises receiving information corresponding to 
at least one of a beamlet fluence parameter, a field segments 
parameter, a couch angles parameter, a gantry angles param-
eter, and a plurality of beam geometry parameters. 
6. The method of claim 1, further comprising receiving 
information corresponding to at least one constraint to be 
incorporated into the treatment plan optimization model. 
7. The method of claim 6, wherein the receiving infor-
mation corresponding to at least one constraint comprises 
receiving information corresponding to at least one of a 
dosimetric constraint and a beam geometry constraint. 
Empirical test's on the patient instances reveal that it is 
beneficial to generate cuts first based on the fractional 
variables q=(v P' y P "'', zp "'k). For each such 0/1 variable that 
satisfies O.Ol<q'<0.99, we solve the corresponding disjunc-
8. The method of claim 7, wherein the developing a 
65 treatment plan optimization model is further based on the at 
least one constraint and the developing a globally optimal 
treatment plan comprises developing a globally optimal 
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treatment plan which opt1m1zes the at least one clinical 
objective subject to the at least one parameter and the at least 
one constraint. 
9. The method of claim 1, wherein at least one of the 
plurality of variables is one of a 0/1 variable and a non-
negative continuous variable. 
10. The method of claim 1, wherein the developing a 
globally optimal treatment plan comprises: 
defining a solution space according to a set of constraints; 
and determining the best solution within the solution 10 
space. 
11. A system for optimizing treatment planning in inten-
sity-modulation radiation therapy (IMRT), the system com-
prising: 
a user interface for enabling a user to specify, at least one 15 
parameter related to IMRT, at least one constraint, and 
at least one clinical objective; 
a treatment plan modeling module configured to develop 
a treatment plan optimization model containing a plu-
rality of variables corresponding to the at least one 20 
parameter related to IMRT, the at least one constraint, 
and the at least one clinical objective; and 
a global optimization module configured to calculate a 
globally optimal treatment plan which optimizes the at 
least one clinical objective subject to the at least one 25 
parameter related to IMRT and the at least one con-
straint. 
12. The system of claim 11, further comprising a visual 
evaluation functionality that supports a visual tool for 
enabling a user to evaluate the globally optimal treatment 30 
plan. 
13. The system of claim 12, wherein the visual evaluation 
functionality is configured to display an isodose curve 
corresponding to the globally optimal treatment plan. 
30 
means for calculating a globally optimal treatment plan 
which optimizes the at least one clinical objective 
subject to the at least one parameter related to IMRT 
and the at least one constraint. 
20. A computer program embodied in a computer-read-
able medium for optimizing treatment planning in intensity-
modulation radiation therapy (IMRT), the computer pro-
gram comprising: 
logic configured to interface with a user and enable the 
user to specify at least one parameter related to IMRT, 
at least one constraint, and at least one clinical objec-
tive; 
logic configured to develop a treatment plan optimization 
model containing a plurality of variables corresponding 
to the at least one parameter related to IMRT, the at 
least one constraint, and the at least one clinical objec-
tive; and 
logic configured to calculate a globally optimal treatment 
plan which optimizes the at least one clinical objective 
subject to the at least one parameter related to IMRT 
and the at least one constraint. 
21. The computer program of claim 20, further compris-
ing a logic configured to provide a visual tool for enabling 
a user to evaluate the globally optimal treatment plan. 
22. The computer program of claim 21, wherein the logic 
configured to provide a visual tool comprises logic config-
ured to display at least one of the following to a user: an 
isodose curve corresponding to the globally optimal treat-
ment plan, a dose-volume histogram corresponding to the 
globally optimal treatment plan, a coverage index corre-
sponding to the globally optimal treatment plan, a confor-
mity index corresponding to the globally optimal treatment 
plan, a homogeneity index corresponding to the globally 
optimal treatment plan, a tumor control and normal tissue 
complication probability index corresponding to the glo-
14. The system of claim 12, wherein the visual evaluation 35 
functionality is configured to display a dose-volume histo-
gram, a coverage index, a conformity index, a homogeneity 
index, a tumor control and normal tissue complication 
probability index, and a display of clinical metrics to the 
user. 40 bally optimal treatment plan, and a display of clinical 
metrics corresponding to the globally optimal treatment 
plan. 
15. The system of claim 11, wherein the user interface is 
configured to enable a user to specify at least one of a 
beamlet fluence parameter, a field segments parameter, a 
couch angles parameter, a gantry angles parameter, and a 
plurality of beam geometry parameters. 
23. The computer program of claim 20, wherein the logic 
configured to interface comprises logic configured to enable 
45 a user to specify at least one of a beamlet fluence parameter, 
a field segments parameter, a couch angles parameter, a 
gantry angles parameter, and a plurality of beam geometry 
parameters. 
16. The system of claim 11, wherein the user interface is 
configured to enable a user to specify a candidate beam 
profile, at least one dose parameter, at least one clinical 
parameter, at least one clinical objective, at least one dosi-
metric constraint, and at least one beam geometry constraint. 50 
17. The system of claim 11, wherein the treatment plan 
modeling module is configured to develop a treatment plan 
optimization model containing at least one 0/1 variable. 
18. The system of claim 11, wherein the global optimi-
zation module is further configured to define a solution 55 
space according to a set of constraints and determine the best 
solution within the solution space. 
19. A system for optimizing treatment planning in inten-
sity-modulation radiation therapy (IMRT), the system com-
prising: 
means for interfacing with an I/O device to enable a user 
to specify at least one parameter related to IMRT, at 
least one constraint, and at least one clinical objective; 
60 
24. The computer program of claim 20, wherein the logic 
configured to interface comprises logic configured to enable 
a user to specify a candidate beam profile, at least one dose 
parameter, at least one clinical parameter, at least one 
clinical objective, at least one dosimetric constraint, and at 
least one beam geometry constraint. 
25. The computer program of claim 20, wherein the logic 
configured to develop a treatment plan optimization model 
comprises logic configured to develop a treatment plan 
optimization model containing at least one 0/1 variable. 
26. The computer program of claim 20, wherein the logic 
configured to calculate a globally optimal treatment plan 
comprises logic configured to define a solution space 
according to a set of constraints and determine the best means for modeling a global system based on a plurality 
of variables corresponding to the at least one parameter 
related to IMRT, the at least one constraint, and the at 
least one clinical objective; and 
65 solution within the solution space. 
* * * * * 
